Vigil Neuroscience Inc

NAS:VIGL (USA)  
$ 1.58 -0.12 (-7.06%) 10:08 PM EST
At Loss
P/B:
0.76
Market Cap:
$ 69.09M
Enterprise V:
$ -29.01M
Volume:
486.22K
Avg Vol (2M):
205.36K
Trade In:
Volume:
486.22K
At Loss
Avg Vol (2M):
205.36K

Business Description

Vigil Neuroscience Inc
NAICS : 325412 SIC : 2834
ISIN : US92673K1088
Description
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.
Name Current Vs Industry Vs History
Cash-To-Debt 8.44
Equity-to-Asset 0.68
Debt-to-Equity 0.15
Debt-to-EBITDA -0.15
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y EPS without NRI Growth Rate 4.94

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 16.57
9-Day RSI 18.75
14-Day RSI 22.57
6-1 Month Momentum % -17.36
12-1 Month Momentum % -13.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.72
Quick Ratio 3.72
Cash Ratio 3.64

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -11.46
Name Current Vs Industry Vs History
ROE % -77.97
ROA % -62.12
ROIC % -373.27
ROC (Joel Greenblatt) % -505.93
ROCE % -74.54

Financials (Next Earnings Date:2025-03-26 Est.)

VIGL's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VIGL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vigil Neuroscience Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.06
Beta 0
Volatility % 70.23
14-Day RSI 22.57
14-Day ATR ($) 0.196292
20-Day SMA ($) 2.1605
12-1 Month Momentum % -13.78
52-Week Range ($) 1.6 - 6.06
Shares Outstanding (Mil) 40.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vigil Neuroscience Inc Filings

Filing Date Document Date Form
No Filing Data

Vigil Neuroscience Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Vigil Neuroscience Inc Frequently Asked Questions

What is Vigil Neuroscience Inc(VIGL)'s stock price today?
The current price of VIGL is $1.58. The 52 week high of VIGL is $6.06 and 52 week low is $1.60.
When is next earnings date of Vigil Neuroscience Inc(VIGL)?
The next earnings date of Vigil Neuroscience Inc(VIGL) is 2025-03-26 Est..
Does Vigil Neuroscience Inc(VIGL) pay dividends? If so, how much?
Vigil Neuroscience Inc(VIGL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1